Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF)

Journal of Cardiology

Volumn 59, Issue 3, 2012, Pages 352-358

  Miyata, Masaaki ^a   Sasaki, Takeshi ^a   Ikeda, Yoshiyuki ^a   Shinsato, Takuro ^a   Kubozono, Takuro ^a   Furusho, Yuko ^a   Kusumoto, Atsushi ^a   Hamasaki, Shuichi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Chronic heart failure; Diuretic

Indexed keywords

ATRIAL NATRIURETIC FACTOR; AZOSEMIDE; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; NORADRENALIN; POTASSIUM; RENIN; SODIUM;

AGED; ARTICLE; BODY WEIGHT; DRUG EFFECT; DRUG SUBSTITUTION; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PROTEIN BLOOD LEVEL; THORAX RADIOGRAPHY; UREA NITROGEN BLOOD LEVEL;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; ECHOCARDIOGRAPHY; FEMALE; FUROSEMIDE; HEART FAILURE; HEART FUNCTION TESTS; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SULFANILAMIDES;

EID: 84860427869     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.12.007     Document Type: Article

References (28)

1. Hunt S.A. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46:e1-e82.
2. Wilson J.R., Reichek N., Dunkman W.B., Goldberg S. Effect of diuresis on the performance of the failing left ventricle in man. Am J Med 1981, 70:234-239.
3. Parker J.O. The effects of oral ibopamine in patients with mild heart failure: a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group. Int J Cardiol 1993, 40:221-227.
4. Richardson A., Bayliss J., Scriven A.J., Parameshwar J., Poole-Wilson P.A., Sutton G.C. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet 1987, 2:709-711.
5. Krück F., Bablok W., Besenfelder E., Betzien G., Kaufmann B. Clinical and pharmacological investigations of the new saluretic azosemid. Eur J Clin Pharmacol 1978, 14:153-161.
6. Psaty B.M., Heckbert S.R., Koepsell T.D., Siscovick D.S., Raghunathan T.E., Weiss N.S., Rosendaal F.R., Lemaitre R.N., Smith N.L., Wahl P.W., Wagner E.H., Furberg C.D. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995, 274:620-625.
7. Furberg C.D., Psaty B.M., Meyer J.V. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995, 92:1326-1331.
8. Yoshida J., Yamamoto K., Mano T., Sakata Y., Nishio M., Ohtani T., Hori M., Miwa T., Masuyama T. Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. Cardiovasc Res 2005, 68:118-127.
9. Tsutsui T., Tsutamoto T., Maeda K., Kinoshita M. Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure. J Cardiovasc Pharmacol 2001, 38:S81-S85.
10. Tomiyama H., Nakayama T., Watanabe G., Shiojima K., Sakuma Y., Yamamoto A., Imai Y., Yoshida H., Doba N. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. Am Heart J 1999, 137:543-548.
11. Kawabata M., Hirao K., Hachiya H., Higuchi K., Tanaka Y., Yagishita A., Inaba O., Isobe M. Role of oral amiodarone in patients with atrial fibrillation and congestive heart failure. J Cardiol 2011, 58:108-115.
12. Kono M., Kisanuki A., Takasaki K., Nakashiki K., Yuasa T., Kuwahara E., Mizukami N., Uemura T., Kubota K., Ueya N., Miyata M., Tei C. Left ventricular systolic function is abnormal in diastolic heart failure: re-assessment of systolic function using cardiac time interval analysis. J Cardiol 2009, 53:437-446.
13. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J.S., Solomon S.D., Spencer K.T., Sutton M.S., Stewart W.J., Chamber Quantification Writing Group, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
14. Tei C. New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995, 26:135-136.
15. Tei C., Ling L.H., Hodge D.O., Bailey K.R., Oh J.K., Rodeheffer R.J., Tajik A.J., Seward J.B. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - A study in normals and dilated cardiomyopathy. J Cardiol 1995, 26:357-366.
16. Tei C., Nishimura R.A., Seward J.B., Tajik A.J. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997, 10:169-178.
17. Remme W.J., Swedberg K., Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001, 22:1527-1560.
18. Maeda K., Tsutamoto T., Wada A., Mabuchi N., Hayashi M., Tsutsui T., Ohnishi M., Sawaki M., Fujii M., Matsumoto T., Kinoshita M. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000, 36:1587-1593.
19. Nishikimi T., Kuwahara K., Nakao K. Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides. J Cardiol 2011, 57:131-140.
20. Saito Y. Roles of atrial natriuretic peptide and its therapeutic use. J Cardiol 2010, 56:262-270.
21. Omland T., Aakvaag A., Bonarjee V.V., Caidahl K., Lie R.T., Nilsen D.W., Sundsfjord J.A., Dickstein K. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996, 93:1963-1969.
22. Rouleau J.L., Packer M., Moyé L., de Champlain J., Bichet D., Klein M., Rouleau J.R., Sussex B., Arnold J.M., Sestier F., Parker J.O., McEwan P., Bernstein V., Cuddy T.E., Lamas G., et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 1994, 24:583-591.
23. Anand I.S., Fisher L.D., Chiang Y.T., Latini R., Masson S., Maggioni A.P., Glazer R.D., Tognoni G., Cohn J.N., Val-HeFT Investigators Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003, 107:1278-1283.
24. McCurley J.M., Hanlon S.U., Wei S.K., Wedam E.F., Michalski M., Haigney M.C. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 2004, 44:1301-1307.
25. Starklint J., Bech J.N., Nyvad O., Jensen P., Pedersen E.B. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure. Scand J Clin Lab Invest 2006, 66:55-66.
26. Westheim A.S., Bostrøm P., Christensen C.C., Parikka H., Rykke E.O., Toivonen L. Hemodynamic and neuroendocrine effects for candoxatril and frusemide in mild stable chronic heart failure. J Am Coll Cardiol 1999, 34:1794-1801.
27. Reed S., Greene P., Ryan T., Cerimele B., Schwertschlag U., Weinberger M., Voelker J. The renin angiotensin aldosterone system and frusemide response in congestive heart failure. Br J Clin Pharmacol 1995, 39:51-57.
28. J-MELODIC Program Committee Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC). Circ J. 2007, 71:1137-1140.